HDA UK Media And Political Bulletin – 20 April 2017

Media Summary

There is no media coverage today.

Parliamentary Coverage

House of Lords, Written Answers, answered on Tuesday 18 April 2017

Department for Business, Energy and Industrial Strategy

Lord Clement-Jones, MP:

Whether they intend to incorporate EU regulations affecting pharmaceutical intellectual property into UK law; and if so, how.

Lord Prior of Brampton, MP:

Pharmaceutical intellectual property is affected by various pieces of EU law. As the White Paper says, to ensure there is maximum clarity as to the law that applies in the UK when we leave the EU, the Great Repeal Bill will convert EU law into UK law. It will also ensure the Government is equipped to make all the necessary corrections to the statute book to ensure a smooth and orderly withdrawal.

Full Coverage

There is no full coverage.

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?

Login